About OrigiMed
OrigiMed is a company based in Shanghai (China) founded in 2016. OrigiMed has raised $10 million across 3 funding rounds from investors including Grand Flight Investment, Star Ventures and Green Pine Capital Partners. OrigiMed operates in a competitive market with competitors including Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Metabolon, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Grand Flight Investment
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OrigiMed
OrigiMed has successfully raised a total of $10M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OrigiMed
OrigiMed has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Grand Flight Investment, Star Ventures and Green Pine Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are offered by the company.
|
Locked | Locked | Locked | |
|
Early & late stage sector-agnostic VC firm investing in the US, Asia and Middle East
|
Locked | Locked | Locked | |
|
Early- and growth-stage investments are directed toward hard technology sectors.
|
Locked | Locked | Locked |
Investor details for OrigiMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OrigiMed
Investment portfolio details for OrigiMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OrigiMed
Detailed financials for OrigiMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Origimed Comparisons
Peer comparison for OrigiMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OrigiMed
OrigiMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, MedGenome, Foundation Medicine, ArcherDX and Metabolon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
Detailed competitors of OrigiMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Origimed
Complete news archive for OrigiMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrigiMed
OrigiMed was founded in 2016.
OrigiMed is headquartered in Shanghai, China.
OrigiMed is a funded company, having raised a total of $10M across 3 funding rounds to date.
OrigiMed was founded in 2016 in Shanghai, China, within the biotechnology sector focused on oncology. Comprehensive diagnostics for cancer patients are performed using next-generation sequencing technologies to identify cancer types. Genetic profiles are analyzed to provide guidance on treatment options. Patient understanding of the disease is supported through these services, with operations centered in China.
OrigiMed's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
OrigiMed has 4 investors. Key investors include Grand Flight Investment, Star Ventures, Green Pine Capital Partners, and IDG Capital.